Cantitate/Preț
Produs

Treatment of Psoriasis: Milestones in Drug Therapy

Editat de Jeffrey M. Weinberg
en Limba Engleză Hardback – 17 dec 2007
Psoriasis is an inherited skin disease that has been diagnosed in 4.5 million adults in the United States. About 10 percent to 30 percent of people with psoriasis also develop psoriatic arthritis, which causes pain, stiffness and swelling in and around the joints. 
The book reviews the clinical manifestations of these two entities. The main focus is on the evolving paradigm of therapy. Topical and ultraviolet therapy are discussed first, followed by traditional systemic therapy. A major focus is on biologic therapies. New agents in development are also reviewed. The book concludes with an evaluation of the quality of life impact of this disease.
This volume provides an in-depth overview of the current state of psoriasis and its management. It is of interest to clinicians, researchers, and even patients who wish to learn more. It is also of interest to those in the pharmaceutical industry, and those in finance who cover the pharmaceutical field.
Citește tot Restrânge

Din seria Milestones in Drug Therapy

Preț: 84004 lei

Preț vechi: 88426 lei
-5% Nou

Puncte Express: 1260

Preț estimativ în valută:
16080 17289$ 13405£

Carte disponibilă

Livrare economică 28 noiembrie-12 decembrie
Livrare express 13-19 noiembrie pentru 3922 lei

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783764377229
ISBN-10: 3764377224
Pagini: 200
Ilustrații: X, 183 p. 2 illus.
Dimensiuni: 165 x 235 x 19 mm
Greutate: 0.58 kg
Ediția:2008
Editura: Birkhäuser Basel
Colecția Birkhäuser
Seria Milestones in Drug Therapy

Locul publicării:Basel, Switzerland

Public țintă

Research

Cuprins

Introduction: History of psoriasis and psoriasis therapy.- The pathophysiology of psoriasis.- Psoriasis and psoriatic arthritis: a clinical review.- Topical therapy I: corticosteroids and vitamin D analogs.- Topical therapy II: retinoids, immunomodulators, and others.- Ultraviolet and laser therapy.- Traditional systemic therapy I: methotrexate and cyclosporine.- Traditional systemic therapy II: retinoids and others (hydroxyurea, thiopurine antimetabolites, mycophenlic acid, sulfasalazine).- Biologic therapy for psoriasis: an overview of infliximab, etanercept, adalimumab, efalizumab, and alefacept.- Biologic and oral therapies in development for the treatment of psoriasis.- Quality of life issues in psoriasis.

Textul de pe ultima copertă

Psoriasis is an inherited skin disease that has been diagnosed in 4.5 million adults in the United States. About 10 percent to 30 percent of people with psoriasis also develop psoriatic arthritis, which causes pain, stiffness and swelling in and around the joints. 
The book reviews the clinical manifestations of these two entities. The main focus is on the evolving paradigm of therapy. Topical and ultraviolet therapy are discussed first, followed by traditional systemic therapy. A major focus is on biologic therapies. New agents in development are also reviewed. The book concludes with an evaluation of the quality of life impact of this disease.
This volume provides an in-depth overview of the current state of psoriasis and its management. It is of interest to clinicians, researchers, and even patients who wish to learn more. It is also of interest to those in the pharmaceutical industry, and those in finance who cover the pharmaceutical field.

Caracteristici

Thorough review of psoriasis and its treatment Review of safety of various therapies Thorough review of novel biologic therapies Includes supplementary material: sn.pub/extras